Difficulty: Medium
Average Score: 66%
Practice
A 13-year-old female complains of an itchy, runny nose during the fall season. She says she experienced similar symptoms around the same time last year. Her family history is significant for hay fever in her mother. Which of the following would be the best choice to treat this patient?
Correct answer
C
Rationale
In this scenario, the best choice to treat the 13-year-old female with seasonal allergic rhinitis is option C: Montelukast. Montelukast is a leukotriene receptor antagonist that helps alleviate symptoms of allergic rhinitis by blocking the action of leukotrienes, which are inflammatory mediators involved in allergic reactions.
Aspirin (option A) is not the best choice in this case because it is not typically used to treat allergic rhinitis and can even exacerbate symptoms in some individuals. Epinephrine (option B) is indicated for severe allergic reactions/anaphylaxis, not for mild allergic rhinitis symptoms. Naproxen (option D) is a nonsteroidal anti-inflammatory drug that may help with symptoms like nasal congestion or headache, but it does not target the underlying allergic response like Montelukast does.
Educationally, it is important to understand the pharmacological basis of different treatment options for allergic rhinitis. Knowing the mechanism of action of Montelukast and how it specifically targets allergic responses can help healthcare providers make informed decisions when managing patients with similar presentations. Additionally, considering the patient's age and history of symptoms, choosing a safe and effective medication like Montelukast is crucial for providing optimal care.
Aspirin (option A) is not the best choice in this case because it is not typically used to treat allergic rhinitis and can even exacerbate symptoms in some individuals. Epinephrine (option B) is indicated for severe allergic reactions/anaphylaxis, not for mild allergic rhinitis symptoms. Naproxen (option D) is a nonsteroidal anti-inflammatory drug that may help with symptoms like nasal congestion or headache, but it does not target the underlying allergic response like Montelukast does.
Educationally, it is important to understand the pharmacological basis of different treatment options for allergic rhinitis. Knowing the mechanism of action of Montelukast and how it specifically targets allergic responses can help healthcare providers make informed decisions when managing patients with similar presentations. Additionally, considering the patient's age and history of symptoms, choosing a safe and effective medication like Montelukast is crucial for providing optimal care.